Abstract
To evaluate the expression of genes encoding cytokines, grow factors and cell cycle regulators in the proliferative endometrium of women with chronic endometritis (CE) compared to controls. We performed a case-control study on seven women with CE as diagnosed by hysteroscopy and histology (Cases) compared to six women without CE (Controls). All women underwent diagnostic hysteroscopy plus endometrial biopsy during the mid-proliferative phase of the menstrual cycle. Endometrial samples were divided into two different aliquots for histological and molecular analyses. The endometrial expression profile of 16 genes encoding proteins involved in the inflammatory process, proliferation and cell cycle regulation/apoptosis was assessed by using high-throughput qPCR. Study endpoints were between-group differences in the expression of VEGF A, VEGF B, VEGF C, EGF, TNF, TGF B1, IFNG, TP73, TP73L, BAXva, CDC2, CDC2va, CCND3, CCNB1, BAX and IL12. RESULTS: VEGF A, VEGF B, VEGF C, EGF, TNF, TGF B1, IFNG, TP73, TP73L, BAXva, CDC2, CDC2va, CCND3, CCNB1 were significantly overexpressed in women with CE compared to controls, while BAX and IL12 had similar expression between groups. In women with CE, we found an altered endometrial expression of genes involved in inflammatory, cell proliferation, and apoptosis processes. The dominance of proliferative and anti-apoptotic activity in CE may potentially promote the development of polyps and hyperplastic lesions.
Highlights
In a previous study on women with chronic endometritis (CE) during the mid-secretory phase, we found an altered expression of genes encoding some proteins involved in endometrial inflammation, replication and apoptosis processes [14]
In the present study we aimed to evaluate the expression of genes involved in inflammation, cell replication and apoptosis in the proliferative endoproteins involved in the inflammatory response
Our study studyfirst firstdemonstrates demonstratesthat thatthe the proliferative endometrium of patients displays an altered expression of genes involved in the response, cell pro‐
Summary
CE may interfere with reproductive capacity, mostly by altering endometrial receptivity [3,4,5,6,7,8,9]. An expert panel developed a series of hysteroscopic diagnostic criteria with the purpose of simplifying CE recognition, with encouraging results. These criteria still need a clinical validation though prospective studies [10]. Histology remains the gold standard for the diagnosis of CE, based on the identification of plasma cells in the endometrial stroma by CD138 immunostaining [8,9]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have